Off-the-Shelf Prostate Stem Cell Antigen–Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer

嵌合抗原受体 前列腺特异性抗原 癌症研究 干细胞 免疫疗法 前列腺癌 抗原 细胞疗法 癌症 免疫学 医学 生物 免疫系统 内科学 细胞生物学
作者
Kun‐Yu Teng,Anthony G. Mansour,Zheng Gang Zhu,Zhiyao Li,Lei Tian,Shoubao Ma,Bo Xu,Ting Lu,Hanyu Chen,David Hou,Jianying Zhang,Saul J. Priceman,Michael A. Caligiuri,Jianhua Yu
出处
期刊:Gastroenterology [Elsevier BV]
卷期号:162 (4): 1319-1333 被引量:140
标识
DOI:10.1053/j.gastro.2021.12.281
摘要

Background & AimsPancreatic cancer (PC) is the third leading cause of cancer-related death with a 5-year survival rate of approximately 10%. It typically presents as a late-stage incurable cancer and chemotherapy provides modest benefit. Here, we demonstrate the feasibility, safety, and potency of a novel human natural killer (NK) cell-based immunotherapy to treat PC.MethodsThe expression of prostate stem cell antigen (PSCA) was evaluated in primary PC at messenger RNA and protein levels. The processes of retroviral transduction, expansion, activation, and cryopreservation of primary human NK cells obtained from umbilical cord blood were optimized, allowing us to develop frozen, off-the-shelf, allogeneic PSCA chimeric antigen receptor (CAR) NK cells. The safety and efficacy of PSCA CAR NK cells also expressing soluble (s) interleukin 15 (PSCA CAR_s15 NK cells) were evaluated in vitro and in vivo.ResultsPSCA was elevated in primary human PC compared with the adjacent or other normal tissues. PSCA CAR_s15 NK cells displayed significant tumor-suppressive effects against PSCA(+) PC in vitro before and after 1 cycle of freeze-thaw. The viability of frozen PSCA CAR_s15 NK cells persisted more than 90 days in vivo after their last infusion and significantly prolonged the survival of mice engrafted with human PC.ConclusionsPSCA CAR_s15 NK cells showed therapeutic efficacy in human metastatic PC models without signs of systematic toxicity, providing a strong rationale to support clinical development. Pancreatic cancer (PC) is the third leading cause of cancer-related death with a 5-year survival rate of approximately 10%. It typically presents as a late-stage incurable cancer and chemotherapy provides modest benefit. Here, we demonstrate the feasibility, safety, and potency of a novel human natural killer (NK) cell-based immunotherapy to treat PC. The expression of prostate stem cell antigen (PSCA) was evaluated in primary PC at messenger RNA and protein levels. The processes of retroviral transduction, expansion, activation, and cryopreservation of primary human NK cells obtained from umbilical cord blood were optimized, allowing us to develop frozen, off-the-shelf, allogeneic PSCA chimeric antigen receptor (CAR) NK cells. The safety and efficacy of PSCA CAR NK cells also expressing soluble (s) interleukin 15 (PSCA CAR_s15 NK cells) were evaluated in vitro and in vivo. PSCA was elevated in primary human PC compared with the adjacent or other normal tissues. PSCA CAR_s15 NK cells displayed significant tumor-suppressive effects against PSCA(+) PC in vitro before and after 1 cycle of freeze-thaw. The viability of frozen PSCA CAR_s15 NK cells persisted more than 90 days in vivo after their last infusion and significantly prolonged the survival of mice engrafted with human PC. PSCA CAR_s15 NK cells showed therapeutic efficacy in human metastatic PC models without signs of systematic toxicity, providing a strong rationale to support clinical development.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
Wy发布了新的文献求助10
3秒前
Code_king发布了新的文献求助10
3秒前
3秒前
Code_king发布了新的文献求助10
3秒前
3秒前
4秒前
Code_king发布了新的文献求助10
4秒前
Code_king发布了新的文献求助10
4秒前
4秒前
Code_king发布了新的文献求助10
4秒前
Code_king发布了新的文献求助10
4秒前
4秒前
Code_king发布了新的文献求助10
4秒前
Code_king发布了新的文献求助10
5秒前
Code_king发布了新的文献求助10
5秒前
5秒前
5秒前
6秒前
GGBond完成签到 ,获得积分10
6秒前
6秒前
王佟发布了新的文献求助10
7秒前
动听的囧完成签到,获得积分10
8秒前
9秒前
9秒前
kiki发布了新的文献求助10
9秒前
9秒前
yin发布了新的文献求助20
9秒前
9秒前
无极微光的应助被修染采纳,获得20
9秒前
李爱国的应助被yyds采纳,获得100
9秒前
Code_king发布了新的文献求助10
9秒前
Code_king发布了新的文献求助10
9秒前
Code_king发布了新的文献求助10
10秒前
小蘑菇的应助被dudu采纳,获得10
10秒前
daomaihu发布了新的文献求助100
10秒前
whs发布了新的文献求助10
11秒前
希望天下0贩的0的应助被胡方采纳,获得10
11秒前
整齐的寄云完成签到,获得积分20
11秒前
wrl2023完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177614
求助须知:如何正确求助?哪些是违规求助? 9568432
关于积分的说明 21799252
捐赠科研通 7772168
什么是DOI,文献DOI怎么找? 3432399
关于科研通互助平台的介绍 2556593
邀请新用户注册赠送积分活动 2477966